Impulsado por la Sociedad Chilena de Medicina Intensiva, el simposio “De los fundamentos a los cuidados de precisión” apuesta por un enfoque multidisciplinar.
🔗https://t.co/qKAbl1z6ZR
Tendré la oportunidad de formar parte de una de las mesas, con ganas de compartir y aprender.
📢 I Curso de PK/PD Avanzado: Desafíos en la optimización terapéutica en casos clínicos complejos
🗓️ 7 de mayo de 2026 | 📍 Hospital del Mar (Barcelona) | 💻 Formato híbrido
Inscripción e información: https://t.co/21YfJeLhi6
Un placer poder participar en esta edición.
🍽️Nutrition in #ICU, from acute phase to beyond
📚 evidence from RCTs
⚖️ impact of evidence on clinical practice & guidelines
🔬micronutrient administration in critical illness
⚙️mechanisms explaining lack of benefit of early high‑dose nutrition
🔮future
🔓https://t.co/BtJAcWcrqy
- TDM of meropenem in critically ill patients on ECMO support. @jrdelbrio@XavierNuvials
- Levetiracetam TDM in neurocritical patients: correlation with eGFR and ARC predictive scale (ARCTIC). @_SoniaGG@plalueza
Collaborative projects presented at #SEMICYUC2024@UCI_vhebron
“Why should we have a clinical pharmacist in the ICU?” A very interesting conference at the @semicyuc Congress. Thanks to @nicole_hunfeld and
@ferrer_ricard!
Empirical antimicrobials in #ICU? Review aimed to provide a step-by-step approach for prescription:
⏱️ assessing need & urgency
🧫 pathogen profiling
⚖️ selecting the right arsenal
🔮 future perspectives
Free to read #FOAMcc on @yourICM
🔓 https://t.co/IcUDyNZgFA
Infermeres i metges de l’@UCI_vhebron han participat com a docents, junt amb altres experts internacionals, al curs d’ECMO avalat per les societats @EuroELSO i @ESICM que s’ha realitzat al congrés europeu d’ECMO #EuroELSO2024!
El curs ha estat dirigit per @jrdelbrio@ECMOHUVH
Every transplant means a new opportunity for life. Today, we share the story of Dr. Ernesto Casis, a patient of #VallHebron and former director of Clinical Laboratories. Thanks to a 🫁 transplant, the 2⃣nd completely robotic in the 🌍, he hopes to travel again, his great passion.
🩸#Pharmacokinetics of #eculizumab in adult and pediatric patients with atypical hemolytic uremic syndrome and C3 glomerulopathy.
📎 https://t.co/uiVN1sTJOM